- Home
- DXCM vs IFF Comparison
DXCM vs IFF Comparison
Compare DXCM & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- IFF
- Stock Information
- Founded
- DXCM 1999
- IFF 1833
- Country
- DXCM United States
- IFF United States
- Employees
- DXCM N/A
- IFF N/A
- Industry
- DXCM Medical/Dental Instruments
- IFF Major Chemicals
- Sector
- DXCM Health Care
- IFF Industrials
- Exchange
- DXCM Nasdaq
- IFF Nasdaq
- Market Cap
- DXCM 28.0B
- IFF 23.2B
- IPO Year
- DXCM 2005
- IFF N/A
- Fundamental
- Price
- DXCM $81.01
- IFF $89.28
- Analyst Decision
- DXCM Buy
- IFF Buy
- Analyst Count
- DXCM 17
- IFF 17
- Target Price
- DXCM $101.29
- IFF $106.67
- AVG Volume (30 Days)
- DXCM 4.0M
- IFF 1.9M
- Earning Date
- DXCM 10-24-2024
- IFF 11-05-2024
- Dividend Yield
- DXCM N/A
- IFF 1.79%
- EPS Growth
- DXCM 83.21
- IFF N/A
- EPS
- DXCM 1.67
- IFF N/A
- Revenue
- DXCM $3,954,000,000.00
- IFF $11,416,000,000.00
- Revenue This Year
- DXCM $13.10
- IFF $0.32
- Revenue Next Year
- DXCM $14.79
- IFF N/A
- P/E Ratio
- DXCM $48.58
- IFF N/A
- Revenue Growth
- DXCM 16.19
- IFF N/A
- 52 Week Low
- DXCM $62.34
- IFF $72.94
- 52 Week High
- DXCM $142.00
- IFF $106.77
- Technical
- Relative Strength Index (RSI)
- DXCM 70.19
- IFF 36.79
- Support Level
- DXCM $77.50
- IFF $90.06
- Resistance Level
- DXCM $79.38
- IFF $91.65
- Average True Range (ATR)
- DXCM 2.56
- IFF 1.71
- MACD
- DXCM 0.59
- IFF 0.50
- Stochastic Oscillator
- DXCM 88.11
- IFF 62.08
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About IFF International Flavors & Fragrances Inc.
International Flavors & Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.